Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8024903 | 0.72 | CHRM2 (0.36) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL29164207 | 0.67 | ALDH1A1 (0.32) | ALDH1A1PKMCHRM2CHRM4CHRM5 | |
| SCHEMBL1698550 | 0.67 | SMN1; SMN2 (0.41) | ALDH1A1PKMCHRM2CHRM4CHRM5 | |
| SCHEMBL5154460 | 0.67 | ALDH1A1 (0.36) | ALDH1A1PKMCHRM2CHRM4CHRM5 | |
| SCHEMBL8212689 | 0.67 | ALDH1A1 (0.36) | ALDH1A1PKMCHRM2CHRM4CHRM5 | |
| SCHEMBL7132050 | 0.65 | ALDH1A1 (0.32) | ALDH1A1PKMCHRM2CHRM4CHRM5 | |
| SCHEMBL8865951 | 0.65 | CHRM2 (0.35) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL28491299 | 0.65 | ALDH1A1 (0.31) | ALDH1A1PKMCHRM2CHRM4CHRM5 | |
| SCHEMBL719804 | 0.65 | MGLL (0.36) | ALDH1A1PKMKMT2AATM | |
| SCHEMBL10644061 | 0.65 | CHRM2 (0.38) | ALDH1A1PKMCHRM2CHRM4CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0762901-B9 | TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING | CIS BIO INT (FR) | 2007-01-17 | — | — | EP | claimed |
| EP-0637968-B2 | TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING | DIATIDE INC (US) | 2006-07-26 | — | — | EP | claimed |
| EP-1004322-B1 | Technetium-99m labeled peptides for thrombus imaging | DIATIDE INC (US) | 2006-06-14 | — | — | EP | claimed |
| EP-0684843-B1 | TECHNETIUM-99m LABELED PEPTIDES FOR DIAGNOSTIC IMAGING OF INFLAMMATION | DIATIDE INC (US) | 2006-05-10 | — | — | EP | claimed |
| EP-0762901-B1 | TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING | BERLEX INC (US) | 2006-04-19 | — | — | EP | claimed |
| US-20050002861-A1 | Enhanced scintigraphic imaging agents for imaging of infection and inflammation | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2005-01-06 | — | — | US | claimed |
| EP-0775160-B1 | CYCLIC HEXAPEPTIDE SOMATOSTATIN ANALOGUES | DIATIDE INC (US) | 2004-08-18 | — | — | EP | claimed |
| EP-1437145-A1 | Enhanced scintigraphic imaging agents for imaging of infection and inflammation | Schering AG (DE) | 2004-07-14 | — | — | EP | claimed |
| EP-0630265-B1 | TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION | DIATIDE INC (US) | 2003-04-16 | — | — | EP | claimed |
| EP-0804481-B1 | SOMATOSTATIN DERIVATIVES AND THEIR RADIOLABELLED PRODUCTS | DIATIDE INC (US) | 2003-04-16 | — | — | EP | claimed |
| US-5620675-A | MEDICAL DIAGNOSIS | DIATECH, INC. (US) | 1997-04-15 | — | — | US | claimed |
| US-5561220-A | POLYPEPTIDE CONTAINING POLYSULFATED GLYCAN | DIATECH, INC. (US) | 1996-10-01 | — | — | US | claimed |
| US-5552525-A | RADIODIAGNOSTIC REAGENTS USING PEPTIDES FOR DETECTION OF INFECTIONS | DIATECH INC. (US) | 1996-09-03 | — | — | US | claimed |
| WO-1995003330-A1 | SOMATOSTATIN DERIVATIVES AND THEIR RADIOLABELLED PRODUCTS | DIATECH, INC. (US) | 1995-02-02 | — | — | WO | claimed |
| WO-1995000553-A1 | RADIOLABELED SOMATOSTATIN-DERIVED PEPTIDES FOR IMAGING AND THERAPEUTIC USES | DIATECH, INC. (US) | 1995-01-05 | — | — | WO | claimed |
| WO-1994023758-A1 | RADIOLABELED COMPOUNDS FOR THROMBUS IMAGING | DIATECH, INC. (US) | 1994-10-27 | — | — | WO | claimed |
| WO-1994000489-A2 | RADIOACTIVELY-LABELED SOMATOSTANTIN-DERIVED PEPTIDES FOR IMAGING AND THERAPEUTIC USES | DIATECH, INC. (US) | 1994-01-06 | — | — | WO | claimed |
| WO-1993025244-A1 | TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING | DIATECH, INC. (US) | 1993-12-23 | — | — | WO | claimed |
| WO-1993023085-A1 | TECHNETIUM-99m LABELED PEPTIDES FOR THROMBUS IMAGING | DIATECH, INC. (US) | 1993-11-25 | — | — | WO | claimed |
| WO-1993017719-A1 | TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION | DIATECH, INC. (US) | 1993-09-16 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050002861-A1 | Enhanced scintigraphic imaging agents for imaging of infection and inflammation | SIGLEC7, CD209, SIGLEC9 | ALDH1A1 4795/4885PKM 2015/4885CHRM2 4629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.